Axikin Pharmaceuticals Garners $2,000,000 New Funding

  • Feed Type
  • Date
    3/30/2012
  • Company Name
    Axikin Pharmaceuticals
  • Mailing Address
    10835 Road To The Cure San Diego, CA 92121
  • Company Description
    The Axikin discovery biology and portfolio of small molecules focuses on novel GPCR and kinase targets central to the inflammatory process, the antagonism of which is predicted to ameliorate allergic respiratory disorders such as rhinitis and asthma, in addition to significantly impacting the inflammation observed in COPD.
  • Website
    http://www.axikin.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.